Rintaro Noro

2.5k total citations
95 papers, 1.8k citations indexed

About

Rintaro Noro is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Rintaro Noro has authored 95 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Pulmonary and Respiratory Medicine, 56 papers in Oncology and 29 papers in Molecular Biology. Recurrent topics in Rintaro Noro's work include Lung Cancer Treatments and Mutations (46 papers), Lung Cancer Research Studies (19 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers). Rintaro Noro is often cited by papers focused on Lung Cancer Treatments and Mutations (46 papers), Lung Cancer Research Studies (19 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers). Rintaro Noro collaborates with scholars based in Japan, United States and Norway. Rintaro Noro's co-authors include Akihiko Gemma, Masahiro Seike, Yuji Minegishi, Kaoru Kubota, Akihiko Miyanaga, Kuniko Matsuda, Akinobu Yoshimura, Tetsuya Okano, Kazuhiro Kitamura and Chie Soeno and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Rintaro Noro

92 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rintaro Noro Japan 25 978 811 697 531 110 95 1.8k
Soji Kakiuchi Japan 21 998 1.0× 910 1.1× 850 1.2× 313 0.6× 98 0.9× 41 1.9k
Yasutaka Yamada Japan 27 1.1k 1.2× 634 0.8× 310 0.4× 883 1.7× 104 0.9× 76 1.8k
Marileila Varella‐Garcia United States 13 618 0.6× 860 1.1× 623 0.9× 277 0.5× 80 0.7× 16 1.4k
Katherine E. Hutchinson United States 19 972 1.0× 536 0.7× 920 1.3× 595 1.1× 93 0.8× 48 1.8k
Neyaz Alam India 21 962 1.0× 387 0.5× 362 0.5× 381 0.7× 161 1.5× 56 1.4k
Charlotte Kopitz Germany 19 981 1.0× 361 0.4× 639 0.9× 787 1.5× 83 0.8× 40 1.7k
Shejuan An China 16 808 0.8× 722 0.9× 601 0.9× 400 0.8× 84 0.8× 35 1.5k
Antoun Toubaji United States 19 1.3k 1.3× 926 1.1× 397 0.6× 395 0.7× 200 1.8× 29 2.0k
Robert Veve United States 10 934 1.0× 1.3k 1.5× 1.3k 1.9× 336 0.6× 161 1.5× 12 2.3k
Minglei Zhuo China 22 501 0.5× 996 1.2× 833 1.2× 607 1.1× 104 0.9× 99 1.6k

Countries citing papers authored by Rintaro Noro

Since Specialization
Citations

This map shows the geographic impact of Rintaro Noro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rintaro Noro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rintaro Noro more than expected).

Fields of papers citing papers by Rintaro Noro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rintaro Noro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rintaro Noro. The network helps show where Rintaro Noro may publish in the future.

Co-authorship network of co-authors of Rintaro Noro

This figure shows the co-authorship network connecting the top 25 collaborators of Rintaro Noro. A scholar is included among the top collaborators of Rintaro Noro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rintaro Noro. Rintaro Noro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takaguri, Akira, et al.. (2025). Circadian clock gene BMAL1 is involved in transforming growth factor β1‐induced fibrotic response in NRK‐49F cells. Cell Biology International. 49(4). 365–373. 1 indexed citations
2.
Nakamichi, Shinji, Kuniko Matsuda, Masaru Matsumoto, et al.. (2024). Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR‐mutated NSCLC with high thrombospondin‐1 expression. Cancer Science. 115(8). 2718–2728. 2 indexed citations
3.
Nakamichi, Shinji, Takehiro Tozuka, Rintaro Noro, et al.. (2023). Successful Treatment with Definitive Concurrent Chemoradiotherapy Followed by Durvalumab Maintenance Therapy in a Patient with Tracheal Adenoid Cystic Carcinoma. Internal Medicine. 62(18). 2731–2735. 4 indexed citations
4.
Miyanaga, Akihiko, Takehiro Tozuka, Yozo Sato, et al.. (2023). Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report. OncoTargets and Therapy. Volume 16. 465–470. 2 indexed citations
5.
Nakamichi, Shinji, Kaoru Kubota, Masaru Matsumoto, et al.. (2023). Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective study. International Journal of Clinical Oncology. 28(7). 872–879.
6.
Tozuka, Takehiro, Masahiro Seike, Yoriko Murata, et al.. (2019). P2.14-41 Risk Factors for Brain Metastasis in Patients with EGFR Mutant Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S845–S845. 1 indexed citations
7.
Lissa, Delphine, Teruhide Ishigame, Rintaro Noro, et al.. (2018). HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients. Lung Cancer. 122. 151–159. 13 indexed citations
8.
Kobayashi, Kenichi, Masahiro Seike, Rintaro Noro, et al.. (2018). Prognostic Significance of NSCLC and Response to EGFR-TKIs of EGFR-Mutated NSCLC Based on PD-L1 Expression. Anticancer Research. 38(2). 753–762. 18 indexed citations
9.
Sugano, Teppei, Masahiro Seike, Rintaro Noro, et al.. (2018). A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumab. OncoTargets and Therapy. Volume 11. 5879–5883. 9 indexed citations
10.
Takahashi, Akiko, Masahiro Seike, Mika Chiba, et al.. (2018). Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer. Scientific Reports. 8(1). 14896–14896. 43 indexed citations
11.
Haznadar, Majda, Qiuyin Cai, Kristopher W. Krausz, et al.. (2016). Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 25(6). 978–986. 45 indexed citations
12.
Noro, Rintaro, Naomi Walsh, Teruhide Ishigame, et al.. (2016). Gene expression classifier for prognosis of early-stage squamous cell carcinoma of the lung. Journal of Thoracic Oncology. 11(2). S38–S39. 1 indexed citations
13.
Sugano, Teppei, Masahiro Seike, Rintaro Noro, et al.. (2015). Inhibition of ABCB1 Overcomes Cancer Stem Cell–like Properties and Acquired Resistance to MET Inhibitors in Non–Small Cell Lung Cancer. Molecular Cancer Therapeutics. 14(11). 2433–2440. 57 indexed citations
14.
Miyanaga, Akihiko, Masahiro Seike, Yasuhiro Kato, et al.. (2015). Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case report. BMC Research Notes. 8(1). 165–165. 9 indexed citations
15.
Minegishi, Yuji, Nariaki Kokuho, Yukiko Miura, et al.. (2014). Clinical features, anti-cancer treatments and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema. Lung Cancer. 85(2). 258–263. 27 indexed citations
16.
Kitamura, Kazuhiro, Masahiro Seike, Tetsuya Okano, et al.. (2013). MiR-134/487b/655 Cluster Regulates TGF-β–Induced Epithelial–Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells. Molecular Cancer Therapeutics. 13(2). 444–453. 161 indexed citations
17.
Shimokawa, Tsuneo, Masahiro Seike, Chie Soeno, et al.. (2012). Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules. British Journal of Cancer. 106(5). 867–875. 15 indexed citations
18.
19.
Miyanaga, Akihiko, Akihiko Gemma, Rintaro Noro, et al.. (2008). Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model. Molecular Cancer Therapeutics. 7(7). 1923–1930. 81 indexed citations
20.
Gemma, Akihiko, Rintaro Noro, Masahiro Seike, et al.. (2005). Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA). British Journal of Cancer. 92(9). 1711–1719. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soji Kakiuchi Breakdown of academic impact, for papers by Yasutaka Yamada Breakdown of academic impact, for papers by Marileila Varella‐Garcia Breakdown of academic impact, for papers by Katherine E. Hutchinson Breakdown of academic impact, for papers by Neyaz Alam Breakdown of academic impact, for papers by Charlotte Kopitz Breakdown of academic impact, for papers by Shejuan An Breakdown of academic impact, for papers by Antoun Toubaji Breakdown of academic impact, for papers by Robert Veve Breakdown of academic impact, for papers by Minglei Zhuo
Rankless by CCL
2026